Aalborg University Hospital — Sponsor Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

9 Recruiting

4 Completed trials

4 Countries active

41 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase II: 7 Phase IV: 8

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Brain abscess 1 Ovarian cancer 1 Herpes simplex meningitis 1 Gastric cancer 1 T-cell lymphoma 1 Follicular lymphoma 1 Pleural mesothelioma 1

Top IMPs

(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE 3 FLUDEOXYGLUCOSE (18F) 3 TOCILIZUMAB 2 ABATACEPT 1 ACICLOVIR 1 ALENDRONATE SODIUM MONOHYDRATE 1 AMIODARONE HYDROCHLORIDE 1 ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350 1 BARICITINIB 1 CARIPRAZINE 1 CEFOTAXIME 1 CEFTRIAXONE SODIUM 1

All trials

15 total

Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending

2024-520042-31-00 Phase IV 1 country ACICLOVIR; VALACICLOVIR HYDROCHLORIDE
The OASE study Pending

2026-525221-21-01 Phase IV 1 country ABATACEPT; BARICITINIB; FILGOTINIB; PREDNISOLONE; TOCILIZUMAB; TOFACITINIB; UPAD…
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lympho… Recruiting

2025-521205-41-00 Phase II 1 country
Pharmacokinetics and pharmacodynamics of amiodarone in critically ill patients treated for atrial fibrillation - a randomised clin Recruiting

2025-521289-88-02 Phase IV 1 country AMIODARONE HYDROCHLORIDE
FAPI PET in Pleural Mesothelioma Recruiting

2024-514301-62-00 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Naldemedine OIBD Recruiting

2023-507744-36-00 Phase II 1 country NALDEMEDINE; TRAMADOL HYDROCHLORIDE
Tocilizumab for Painful Chronic Pancreatitis (TOPAC-trial) Recruiting

2023-510084-35-00 Phase II 1 country SODIUM CHLORIDE; TOCILIZUMAB
A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic c… Recruiting

2024-514291-41-00 Phase II 1 country GEMCITABINE; PACLITAXEL ALBUMIN-BOUND
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) Recruiting

2024-517170-20-01 Phase IV 1 country CARIPRAZINE
A trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents of the large bowel before colonoscopy (examination… Recruiting

2024-518544-21-00 Phase IV 1 country ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3…
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Phase IV 4 countries CEFOTAXIME; CEFTRIAXONE SODIUM; CLINDAMYCIN; LINEZOLID; MEROPENEM ANHYDROUS; MET…
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-Esophage… Ended

2023-505916-40-01 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients with Ovarian Cancer Ended

2023-505938-98-00 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
Tramadol OIBD Ended

2022-500108-23-00 Phase IV 1 country
Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) and the effect of antiresorptive treatment on glycemic markers Ended

2024-514148-99-00 Phase IV 1 country ALENDRONATE SODIUM MONOHYDRATE

Showing 1–15 of 15 trials

← All sponsors A–Z